Some animal studies suggest that GLP-1 agonists reduce microglial activation in the spinal cord
Emerging research involving tripeptides as anticancer agents has explored alternative strategies to improve survival rates in cancer patients worldwide
Dulaglutide demonstrated superior glycemic control compared to exenatide and insulin glargine in the AWARD studies, with greater HbA1c reductions and improved patient satisfaction while it was noninferior to liraglutide in HbA1c reduction [75]
It helps regulate blood sugar levels, improve insulin response, and reduce appetite, making it an effective solution for long-term metabolic health management
[DOI] [PubMed] [Google Scholar] 44.Chang C.H., Tsai W.C., Hsu Y.H., Pang J.H.S
doi: 10.1111/dme.13160 67 SteinbergWMRosenstockJWaddenTADonsmarkMJensenCBDeVriesJH